Short for body protecting compound, this peptide may also help fight inflammation and improve gut health
Mol Med Report 5:625630 Li C, Zhao Y, Cheng J, Guo J, Zhang Q, Zhang X, Ren J, Wang F, Huang J et al (2019) A proresolving peptide nanotherapy for site-specific treatment of inflammatory bowel disease by regulating proinflammatory microenvironment and gut microbiota
Structurally, it is a 39-amino acid modified peptide, attached to a C20 fatty diacid moiety, which facilitates albumin binding
Research suggests the 1:1 ratio in REGEN (5 mg of each) provides optimal healing benefits while maintaining safety profiles established for each individual peptide
For side effect details, see our GHK-Cu side effects guide